“Ocular Hypotensive Efficacy of a New Liposomal Latanoprost Formulation Administered by Different Routes for Experimental Ocular Hypertension”. Ukrainian Journal of Ophthalmology , no. 2, Aug. 2025, pp. 37-41, https://doi.org/10.31288/oftalmolzh202223741.